University of California San Francisco
Give to UCSFTaking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.
Dean Mary Anne Koda-Kimble, “a major force in shaping, advocating and expanding clinical pharmacy practice in the U.S. and around the world,” will receive the highest honor from the American Pharmacists Association.
New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.
A landmark textbook focusing on lesbian health, based on extensive research and the clinical experience of its 46 chapter authors, is now available.
UCSF Chancellor Susan Desmond-Hellmann outlines a vision for faster development of better, cheaper drugs to fight cancer.
The UCSF Resource Allocation Program (RAP) is accepting applications for the spring 2010 funding cycle.